| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.89T | 2.16T | 2.32T | 2.55T | 2.50T |
| Gross Profit | 420.76B | 457.06B | 401.22B | 392.53B | 496.31B |
| EBITDA | 85.13B | 77.40B | 40.84B | 60.65B | 159.18B |
| Net Income | 47.44B | 36.09B | -149.98B | -260.84B | 73.99B |
Balance Sheet | |||||
| Total Assets | 1.43T | 1.45T | 1.59T | 1.77T | 1.96T |
| Cash, Cash Equivalents and Short-Term Investments | 238.45B | 279.31B | 227.13B | 262.06B | 287.36B |
| Total Debt | 437.01B | 547.04B | 597.71B | 735.67B | 633.76B |
| Total Liabilities | 1.13T | 1.29T | 1.43T | 1.55T | 1.49T |
| Stockholders Equity | 281.85B | 154.65B | 143.18B | 208.74B | 454.57B |
Cash Flow | |||||
| Free Cash Flow | -22.00B | -28.39B | 83.62B | -28.82B | 27.57B |
| Operating Cash Flow | -191.00M | -1.59B | 124.50B | 14.75B | 75.16B |
| Investing Cash Flow | 71.70B | 103.74B | 10.88B | -40.97B | -31.45B |
| Financing Cash Flow | -105.80B | -74.77B | -149.67B | -18.48B | -124.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥4.41T | 32.60 | 1.37% | 2.29% | 2.77% | 500.36% | |
73 Outperform | ¥392.02B | 21.74 | 5.53% | 3.55% | 5.54% | 128.65% | |
66 Neutral | ¥167.68B | 9.71 | 13.53% | 1.34% | -3.63% | -14.77% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥8.33T | 44.23 | 4.25% | 1.99% | -4.84% | -48.25% | |
53 Neutral | ¥21.54T | -64.19 | 14.45% | 0.55% | -3.68% | -129.40% | |
48 Neutral | ¥396.11B | 8.52 | ― | ― | -12.38% | 31.41% |